Biologic progression in non-Hodgkin's lymphoma a flow cytometric study
- 1 June 1990
- Vol. 65 (11) , 2564-2571
- https://doi.org/10.1002/1097-0142(19900601)65:11<2564::aid-cncr2820651128>3.0.co;2-p
Abstract
The nuclear DNA content of 37 primary non-Hodgkin's lymphomas both at presentation and at relapse was determined by flow cytometric analysis from paraffin-embedded tissue to investigate changes in DNA ploidy and S-phase fraction (SPF) during the course of the disease, and their association with survival. The repeat biopsies were done from 5 months to 15 years after the diagnosis. Four low-grade lymphomas according to the Working Formulation transformed into intermediate-grade lymphomas (four of 11, 36%), and four intermediate-grade lymphomas into high-grade lymphomas during the follow-up (four of 16, 25%), and five of these eight transformed lymphomas were fatal within 18 months after relapse. The SPF correlated strongly with poor prognosis if measured either from the primary biopsy (P = 0.008), the first (P = 0.009), or the latest repeat biopsy (P = 0.006). If SPF was ≥ 6% larger in a repeat biopsy than at presentation prognosis was poor; six of nine such patients died from lymphoma within 11 months from recurrence. An increase of ≥ 6% in the SPF was more common in high-grade (four of nine, 44%) and intermediate-grade (four of 16, 25%) lymphomas than in low-grade lymphomas (one of 11, 9%), and it was occasionally (three of nine) associated with a morphologic change. In a few cases a repeat biopsy was diploid despite DNA aneuploidy at presentation. In conclusion, the study provides evidence that not only may low-grade lymphomas transform into higher grade lymphomas, but high-grade lymphomas may also frequently transform into more malignant forms during the course of the disease. The SPF is useful in monitoring the biological behavior of non-Hodgkin's lymphoma, and it appears to give information not obtained by histologic study alone.This publication has 32 references indexed in Scilit:
- Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non‐Hodgkin lymphomasThe Journal of Pathology, 1989
- Prognostic indicators in centroblastic-centrocytic lymphoma.Journal of Clinical Pathology, 1988
- The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival materialEuropean Journal of Cancer and Clinical Oncology, 1987
- Non-Hodgkin Lymphoma: Multivariate analysis of prognostic factors including fraction of S-phase cellsActa Oncologica, 1987
- Cell proliferation and DNA content in non-hodgkin' s lymphoma: Flow cytometry in relation to lymphoma classificationCancer, 1986
- Prognostic Value of DNA/RNA Flow Cytometry of B-Cell Non-Hodgkin's Lymphoma: Development of Laboratory Model and Correlation with Four Taxonomic SystemsAnnals of the New York Academy of Sciences, 1986
- Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphomaHematological Oncology, 1985
- Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometryBlood, 1985
- Histologic progression in non-Hodgkin's lymphomaBlood, 1982
- Non-hodgkin's lymphoma.A study of the evolution of the disease based upon 92 autopsied casesCancer, 1979